High-Glucose High-Fat Culture Conditions

Five times plasma glucose, and a fatty acid supplement that is not a diet.

The numbers, in context

ConditionConcentrationCompared with plasma
Plasma, fasting4.4–5.0 mMReference
Plasma, postprandial6–8 mMReference
Diabetes, poor control8–15 mM2–3× fasting
RPMI 164011.1 mM2× fasting
DMEM, low glucose5.6 mMNear fasting
DMEM, high glucose25 mM5× fasting
"High glucose" in most papers25–30 mM5–6× fasting

Two consequences follow. First, cells grown in RPMI are already in a hyperglycaemic medium, so a "normal glucose" control at 11 mM is not normal. Second, a "high glucose" condition at 25 mM is above anything a patient reaches, including in diabetic ketoacidosis, where values are high but not sustained for days in every tissue.

Important distinction. A supraphysiological stimulus can be a legitimate tool — it produces a robust, reproducible phenotype. It is not a model of diabetes. The claim should say which it is.

Osmotic control

Glucose at 25 mM adds roughly 25 mOsm, which is a real osmotic load on a cell.

ControlOsmolarity matchedValidNote
Mannitol, 25 mMYesYesStandard choice
L-glucose, 25 mMYesYesNot metabolised; expensive
NaCl, 25 mMYesYesChanges ionic strength; acceptable
NoneNoNoThe effect is unattributable

The control is absent in a large fraction of published high-glucose experiments. Without it, an effect can be osmotic, and osmotic stress activates overlapping signalling with metabolic stress — including NF-κB, p38 and cell-cycle arrest.

Caveat on mannitol. Mannitol is not always inert: it is taken up slowly by some cells and can affect organic osmolyte handling. L-glucose is the cleaner control but costs more. Either is better than none.

Fatty acids are not a diet

Feature of a high-fat dietPresent in culture
Excess energy intakeNo
Adipose storage and releaseNo
Chylomicron and lipoprotein transportNo
Gut-derived signals (GLP-1, bile acids)No
Systemic insulin responseNo
Elevated fatty acid supply to the cellYes, as BSA-bound supplement

A culture condition with 200 µM palmitate delivers fatty acids to a cell. A high-fat diet delivers fatty acids, changes adipose function, alters enteroendocrine signalling and produces hyperinsulinaemia. The two share one variable out of several, and "high-fat culture model" implies more than it delivers.

Important distinction. What a fatty acid supplement models is substrate supply to a cell, which is the relevant variable for lipotoxicity, ER stress and lipid droplet formation. It is not the relevant variable for insulin resistance as a systemic phenomenon.

Composition of the fat

SupplementReceptor/routeOutcome
Palmitate (C16:0)TLR4, ER stress, ceramideInjury, inflammation
Oleate (C18:1)EsterificationStorage, protection against palmitate
Linoleate (C18:2)Oxidation-proneLipid peroxidation, ferroptosis sensitisation
Mixed (commercial lipid mix)MultipleReproducible but undefined
Lipoprotein-derived cholesterolLDLRFoam cell formation, cholesterol crystal

Saturated and unsaturated fatty acids are not interchangeable, and a "high-fat" condition should specify the species. The oleate:palmitate ratio is the single most informative parameter, as it is in the hepatocyte steatosis model.

Duration and adaptation

DurationWhat is being measured
1–6 hAcute signalling and biophysics
24–48 hTranscriptional adaptation, lipid accumulation
72 h–1 weekSelection; the surviving population is different
> 1 weekClonal adaptation, not a response

Caveat on long exposures. Any condition that reduces proliferation produces a population selected for tolerance. After two weeks at 25 mM glucose, the cells that remain are not "adapted cells" in a physiological sense; they are the minority that grew. Distinguishing adaptation from selection requires a washout and recovery arm, or a proliferation-matched control.

Combined glucolipid conditions

DesignTestsConfound
High glucose aloneHexosamine, osmotic, methylglyoxal effectsMissing lipogenic substrate
Palmitate aloneLipid-mediated stressMissing insulin and glucose drive
High glucose + high insulinLipogenic inductionInsulin desensitisation
High glucose + palmitateGlucolipotoxicityAttribution impossible
All threeThe in vivo loopAttribution impossible, and no single-variable control

The second and third rows are useful because they isolate a mechanism. The fifth is the closest to the disease and the least able to say what caused what. Run the isolated arms alongside it if attribution is the claim.

Readout note. Ammonia and osmolarity should be measured in long high-glucose cultures: glutamine degrades spontaneously in medium at 37 °C, and the resulting ammonia contributes to the phenotype independently of glucose. A glucose-only interpretation of a 72-hour experiment is incomplete without it.

Failures that recur

  • • No osmotic control. The most common omission in this literature.
  • • "Normal glucose" control at 11 mM. That is already above plasma.
  • • Supraphysiological condition described as a disease model.
  • • Fatty acid species unstated. Palmitate and oleate do opposite things.
  • • BSA ratio unstated, so free concentration is unknown.
  • • Long exposure read as adaptation. It is selection.
  • • Ammonia not measured in multi-day cultures.
  • • Insulin concentration unstated in glucolipid protocols.

Where this connects

  • • Insulin resistance models article supplies the interpretation of what each combination produces.
  • • MASH cell models article supplies the fatty acid ratio logic for hepatocytes.
  • • Amino acid pillar supplies the glutamine degradation and ammonia problem in aged medium.
  • • Disease pillar supplies the frame: a culture condition is one variable, a disease is several.

Scientific interpretation and experimental design

  • • State the concentration and the plasma comparison.
  • • Run an osmotic control. Mannitol or L-glucose.
  • • Do not call it a disease model. Call it a stimulus.
  • • Specify the fatty acid species. Ratio matters more than total.
  • • Report BSA molar ratio.
  • • Keep exposures short enough to be a response, not a selection.
  • • Measure ammonia and osmolarity in long cultures.

Selected references for further reading

  • • Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813–820.
  • • Nishikawa T, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404:787–790.
  • • Listenberger LL, et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. PNAS. 2003;100:3077–3082.
  • • Tritsch GL, Moore GE. Spontaneous decomposition of glutamine in cell culture media. Experimental Cell Research. 1962;28:360–364.

Related Products

Product name Cat.No. Species Gene ID
PBRM1 Knockout A-549 Cell Line EDJ0001-K01 Human 55193 Details Get a Quote
YTHDC1 Knockout A-549 Cell Line EDC07652 Human 91746 Details Get a Quote
TP53 Knockout HCT 116 Cell Line EDC07854 Human 7157 Details Get a Quote
Sirt2 Knockout MH-S Cell Line EDJ-KQ78173 Mouse 64383 Details Get a Quote
TFE3 Knockout KGN Cell Line EDJ-KQ48 Human 7030 Details Get a Quote
Stub1 Knockout MB49 Cell Line EDJ-KQ53 Mouse 56424 Details Get a Quote
ARID1A Knockout SNK-6 Cell Line EDJ-KQ64 Human 8289 Details Get a Quote
Tet1 Knockout Kupffer Cell Line EDJ-KQ88 Mouse 52463 Details Get a Quote
NR1H3 Knockout HEK293T Cell Line EDJ-KQ109 Human 10062 Details Get a Quote
NR1H2 Knockout HEK293T Cell Line EDJ-KQ110 Human 7376 Details Get a Quote
RPS6KB2 Knockout HEK293 Cell Line EDJ-KQ125 Human 6199 Details Get a Quote
SMAD6 Knockout HEK293 Cell Line EDJ-KQ126 Human 4091 Details Get a Quote
JUN Knockout HEK293 Cell Line EDJ-KQ176 Human 3725 Details Get a Quote
JUN Knockout HEK293T Cell Line EDJ-KQ184 Human 3725 Details Get a Quote
ALKBH5 Knockout HEK293 Cell Line EDJ-KQ186 Human 54890 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: